Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
14cc of lidocaïne®----[1] 149
29060X----[2] 13, 149
3Anatomical Landmark-guided Suprascapular Nerve Block----[1] 149
4Baclofen[1] Baclofen[1] D00241 [2] GABBR1,
GABBR2 💬		[7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[7] 2, 10, 13, 18, 65, 149, 206
5Balance[1] Isoxaflutole---[8] 6, 11, 13, 81, 113, 122, 149, 299
6Behavioral: AO+VR----[1] 149
7Behavioral: CO+VR----[1] 149
8Botox[1] Botulinum toxin type A[1] D00783 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[6] 2, 6, 13, 51, 149, 226
9Botulinum Toxin----[3] 6, 13, 149
10Botulinum toxin A[1] Botulinum toxin type A[1] D00783 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[4] 13, 51, 149, 226
11BOTULINUM TOXIN TYPE A[1] Botulinum toxin type A[1] D00783 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
12Brivaracetam[1] Brivaracetam[1] D08879 [1] SV2A 💬[1] ECM-receptor interaction 💬[2] 149, 309
13CO----[6] 6, 13, 53, 70, 85, 149
14Diagnostic Test: gait analysis----[1] 149
15Diagnostic Test: Nociceptor flexor reflex----[1] 149
16Edonerpic[1] Edonerpic---[1] 149
17FENFLURAMINE[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[4] 140, 144, 145, 149
18Gradient----[4] 58, 86, 149, 215
19HC-58----[1] 149
20Lacosamide[1] Lacosamide[1] D07299 [2] SCN3A,
SCN9A 💬		[1] Taste transduction 💬[3] 2, 46, 149
21Medicinal air----[1] 149
22Melatonin[1] Melatonin[1] D08170 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[12] 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202
23MEOPA----[1] 149
24Other: Review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.[1] Melatonin[1] D08170 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 149
25Other: The patients' parents have to complete the VINELAND II adaptive behavior scales scoring, The Sleep Disturbance Scale for Children (SDSC) and Horne & Ostberg Circadian Typology Questionnaire----[1] 149
26Oxybate[1] gamma-Hydroxybutyric acid---[2] 6, 149
27Padsevonil[1] Padsevonil[1] D11842 [3] SV2A,
SV2B,
SV2C 💬		[1] ECM-receptor interaction 💬[1] 149
28Placebo----[27] 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
29Sodium Oxybate[2] Sodium oxybate,
gamma-Hydroxybutyric acid		[1] D05866 --[2] 6, 149
30SPM927----[1] 149
31T-817MA----[1] 149
32Time delay treatment of botulinum toxin----[1] 149
33Triheptanoin[1] Triheptanoin[1] D11465 --[10] 2, 8, 65, 149, 156, 248, 256, 257, 317, 324
34Ucb 34714----[2] 149, 309
35Ultrasound-guided Suprascapular Nerve Block----[1] 149
36Upper limb muscle block----[1] 149